BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27450420)

  • 1. Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer.
    Kondo T; Hara I; Takagi T; Kodama Y; Hashimoto Y; Kobayashi H; Iizuka J; Omae K; Yoshida K; Tanabe K
    Int J Clin Oncol; 2017 Feb; 22(1):145-152. PubMed ID: 27450420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
    Matin SF; Sfakianos JP; Espiritu PN; Coleman JA; Spiess PE
    J Urol; 2015 Dec; 194(6):1567-74. PubMed ID: 26094807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
    J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of regional lymphadenectomy in accordance with primary tumor location on laparoscopic nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective study.
    Abe T; Takada N; Matsumoto R; Osawa T; Sazawa A; Maruyama S; Tsuchiya K; Harabayashi T; Minami K; Nagamori S; Hatanaka KC; Tanaka Y; Shinohara N; Nonomura K
    J Endourol; 2015 Mar; 29(3):304-9. PubMed ID: 25255401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).
    Chappidi MR; Kates M; Johnson MH; Hahn NM; Bivalacqua TJ; Pierorazio PM
    Urol Oncol; 2016 Dec; 34(12):531.e15-531.e24. PubMed ID: 27476032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: a prospective study.
    Kondo T; Hara I; Takagi T; Kodama Y; Hashimoto Y; Kobayashi H; Iizuka J; Omae K; Yoshida K; Tanabe K
    Int J Urol; 2014 May; 21(5):453-9. PubMed ID: 24754341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative risk factors for extraurothelial recurrence in patients with ureteral cancer treated with radical nephroureterectomy.
    Ito K; Kuroda K; Asakuma J; Hamada S; Tachi K; Tasaki S; Sato A; Horiguchi A; Seguchi K; Asano T
    J Urol; 2014 Jun; 191(6):1685-92. PubMed ID: 24423440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
    Dominguez-Escrig JL; Peyronnet B; Seisen T; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Gontero P; Lam T; MacLennan S; Mostafid H; Palou J; van Rhijn BWG; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol Focus; 2019 Mar; 5(2):224-241. PubMed ID: 29158169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
    Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
    World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma.
    Seisen T; Shariat SF; Cussenot O; Peyronnet B; Renard-Penna R; Colin P; Rouprêt M
    World J Urol; 2017 Apr; 35(4):535-548. PubMed ID: 26809456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
    Urology; 2007 Feb; 69(2):265-9. PubMed ID: 17320661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
    J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of template-based lymphadenectomy in reducing the risk of regional node recurrence after nephroureterectomy in patients with renal pelvic cancer.
    Kondo T; Hara I; Takagi T; Kodama Y; Hashimoto Y; Kobayashi H; Iizuka J; Omae K; Ikezawa E; Yoshida K; Tanabe K
    Jpn J Clin Oncol; 2014 Dec; 44(12):1233-8. PubMed ID: 25271269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
    Hurel S; Rouprêt M; Ouzzane A; Rozet F; Xylinas E; Zerbib M; Berod AA; Ruffion A; Adam E; Cussenot O; Houlgatte A; Phé V; Nouhaud FX; Bensadoun H; Delage F; Guillotreau J; Guy L; Karsenty G; De La Taille A; Colin P;
    BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
    Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
    World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract.
    Miyake H; Hara I; Gohji K; Arakawa S; Kamidono S
    Br J Urol; 1998 Oct; 82(4):494-8. PubMed ID: 9806176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.
    Roscigno M; Shariat SF; Freschi M; Margulis V; Karakiewizc P; Suardi N; Remzi M; Zigeuner R; Bolenz C; Kikuchi E; Weizer A; Bensalah K; Sagalowsky A; Koppie TM; Raman J; Fernández M; Ströbel P; Kabbani W; Langner C; Wheat J; Guo CC; Kassouf W; Haitel A; Wood CG; Montorsi F
    Urology; 2009 Nov; 74(5):1070-4. PubMed ID: 19883824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical templates of lymph node dissection for upper tract urothelial carcinoma: a systematic review of the literature.
    Campi R; Minervini A; Mari A; Hatzichristodoulou G; Sessa F; Lapini A; Sessa M; Gschwend JE; Serni S; Roscigno M; Carini M
    Expert Rev Anticancer Ther; 2017 Mar; 17(3):235-246. PubMed ID: 28103449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study.
    Xylinas E; Kluth L; Rieken M; Rouprêt M; Al Hussein Al Awamlh B; Clozel T; Sun M; Karakiewicz PI; Gonen M; Shariat SF
    Urol Oncol; 2017 Jan; 35(1):33.e21-33.e26. PubMed ID: 27816402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Yamashita R; Watanabe R; Ito I; Shinsaka H; Nakamura M; Matsuzaki M; Niwakawa M
    Int Urol Nephrol; 2017 Mar; 49(3):425-430. PubMed ID: 28078533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.